臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hung j s"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 51-75 of 109 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-06-01T06:31:32Z	Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer	Li Y.-I.;Hung J.-S.;Yu T.-Y.;Liou J.-M.;Wei J.-N.;Kao H.-L.;Chuang L.-M.;Shun C.-T.;Lee P.-H.;Lai H.-S.;Su C.-Y.;Hung-Yuan Li;Liang J.-T.; Li Y.-I.; Hung J.-S.; Yu T.-Y.; Liou J.-M.; Wei J.-N.; Kao H.-L.; Chuang L.-M.; Shun C.-T.; Lee P.-H.; Lai H.-S.; Su C.-Y.; HUNG-YUAN LI; Liang J.-T.
臺大學術典藏	2020-03-07T06:56:33Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.
臺大學術典藏	2020-03-07T06:56:25Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liau J.-Y.; Liang J.-T.; Tsai J.-H.; Liang Y.-H.; Lin Y.-.; Lin Y.-.;Liang Y.-H.;Tsai J.-H.;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.
臺大學術典藏	2020-03-07T06:56:23Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Yih-Leong Chang;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-03-07T06:56:18Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Chen K.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.
臺大學術典藏	2020-03-06T08:25:10Z	β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma	Chang H.-H.; Chen C.-H.; Chou C.-H.; Liao Y.-F.; Huang M.-J.; Chen Y.-H.; Wang W.-J.; Huang J.; Hung J.-S.; Ho W.-L.; YUNG-MING JENG; Che M.-I.; Lee H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Lin D.-T.; Lin K.-H.; Hsu W.-M.; Huang M.-C.
臺大學術典藏	2020-03-06T05:26:20Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-06T05:26:15Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-06T05:26:12Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-03-06T05:26:09Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-05T12:22:25Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	Lin Y.-L.; Liau J.-Y.; SHAN-CHI YU; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-05T07:31:48Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	Lin Y.-.;Liang Y.-H.;Jia-Huei Tsai;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; JIA-HUEI TSAI; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-05T07:31:46Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Jia-Huei Tsai;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Yeh K.-H.; Cheng A.-L.; Chang Y.-L.; Lin L.-I.; Tseng L.-H.; JIA-HUEI TSAI; Liang J.-T.; Lin B.-R.; Hung J.-S.
臺大學術典藏	2020-03-05T07:31:45Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Chen K.-H.; Lin Y.-L.; Liau J.-Y.; JIA-HUEI TSAI; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-05T06:28:43Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	Cheng A.-L.; Yeh K.-H.; Chang Y.-L.; Hung J.-S.; Lin Y.-L.; JAU-YU LIAU; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.
臺大學術典藏	2020-03-05T06:28:40Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	Cheng A.-L.; Chang Y.-L.; Yeh K.-H.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liang J.-T.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.; JAU-YU LIAU
臺大學術典藏	2020-03-05T06:28:37Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-03-05T06:28:33Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Chen K.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-05T03:20:18Z	β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma	Chang H.-H.; Chen C.-H.; Chou C.-H.; Liao Y.-F.; Huang M.-J.; Chen Y.-H.; Wang W.-J.; Huang J.; Hung J.-S.; Ho W.-L.; Jeng Y.-M.; Che M.-I.; Lee H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Lin D.-T.; Lin K.-H.; WEN-MING HSU; Huang M.-C.
臺大學術典藏	2020-03-05T03:20:15Z	β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells	Che M.-I.;Huang J.;Hung J.-S.;Lin Y.-C.;Huang M.-J.;Lai H.-S.;Wen-Ming Hsu;Liang J.-T.;Huang M.-C.; Che M.-I.; Huang J.; Hung J.-S.; Lin Y.-C.; Huang M.-J.; Lai H.-S.; WEN-MING HSU; Liang J.-T.; Huang M.-C.
臺大學術典藏	2020-03-02T06:30:11Z	The molecular chaperone cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK	Huang J.; Che M.-I.; NENG-YU LIN; Hung J.-S.; Huang Y.-T.; Lin W.-C.; Huang H.-C.; Lee P.-H.; Liang J.-T.; Huang M.-C.
臺大學術典藏	2020-03-02T06:05:28Z	COSMC Is Overexpressed in Proliferating Infantile Hemangioma and Enhances Endothelial Cell Growth via VEGFR2	Lee J.-J.; Chen C.-H.; Chen Y.-H.; Huang M.-J.; Huang J.; Hung J.-S.; Chen M.-T.; MIN-CHUAN HUANG
臺大學術典藏	2020-03-02T06:05:26Z	β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma	Chang H.-H.; Chen C.-H.; Chou C.-H.; Liao Y.-F.; Huang M.-J.; Chen Y.-H.; Wang W.-J.; Huang J.; Hung J.-S.; Ho W.-L.; Jeng Y.-M.; Che M.-I.; Lee H.; Lu M.-Y.; Yang Y.-L.; Jou S.-T.; Lin D.-T.; Lin K.-H.; Hsu W.-M.; MIN-CHUAN HUANG
臺大學術典藏	2020-03-02T06:05:26Z	MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer	MIN-CHUAN HUANG; Chen C.-H.; Wang S.-W.; Chen C.-W.; Huang M.-R.; Hung J.-S.; Huang H.-C.; Lin H.-H.; Chen R.-J.; Shyu M.-K.
臺大學術典藏	2020-03-02T06:05:24Z	β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer	Chen C.-H.; Wang S.-H.; Liu C.-H.; Wu Y.-L.; Wang W.-J.; Huang J.; Hung J.-S.; Lai I.-R.; Liang J.-T.; MIN-CHUAN HUANG

Showing items 51-75 of 109 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2815037
	???header.visitor??? : 27359004 ???header.onlineuser??? : 870 ???header.sponsordeclaration???